Literature DB >> 11351039

Typing of human papillomavirus by pyrosequencing.

B Gharizadeh1, M Kalantari, C A Garcia, B Johansson, P Nyrén.   

Abstract

The possibility of using a new bioluminometric DNA sequencing technique, called pyrosequencing, for typing of human papillomaviruses (HPV) was investigated. A blinded pyrosequencing test was performed on an HPV test panel of 67 GP5+/GP6+ PCR-derived amplification products. The 67 clinical DNA samples were sequenced up to 25 bases and sequences were searched using BLAST. All of the samples were correctly genotyped by pyrosequencing and the results were unequivocally in accordance with the results obtained from conventional DNA sequencing. Pyrosequencing was found to be a fast and efficient tool for identifying individual HPV types. Furthermore, pyrosequencing has the capability of determining novel HPV types as well as HPV sequence variants harboring mutation(s). The method is robust and well suited for large-scale programs.

Entities:  

Mesh:

Year:  2001        PMID: 11351039     DOI: 10.1038/labinvest.3780276

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  22 in total

1.  Viral and microbial genotyping by a combination of multiplex competitive hybridization and specific extension followed by hybridization to generic tag arrays.

Authors:  Baback Gharizadeh; Max Käller; Pål Nyrén; Anders Andersson; Mathias Uhlén; Joakim Lundeberg; Afshin Ahmadian
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

Review 2.  Pyrosequencing: sequence typing at the speed of light.

Authors:  Matthew A Diggle; Stuart C Clarke
Journal:  Mol Biotechnol       Date:  2004-10       Impact factor: 2.695

3.  Type-specific multiple sequencing primers: a novel strategy for reliable and rapid genotyping of human papillomaviruses by pyrosequencing technology.

Authors:  Baback Gharizadeh; Maria Oggionni; Biying Zheng; Edit Akom; Nader Pourmand; Afshin Ahmadian; Keng-Ling Wallin; Pål Nyrén
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

4.  Direct amplification of single-stranded DNA for pyrosequencing using linear-after-the-exponential (LATE)-PCR.

Authors:  Jesse J Salk; J Aquiles Sanchez; Kenneth E Pierce; John E Rice; Kevin C Soares; Lawrence J Wangh
Journal:  Anal Biochem       Date:  2006-02-28       Impact factor: 3.365

5.  Methodological improvements of pyrosequencing technology.

Authors:  Baback Gharizadeh; Michael Akhras; Nader Nourizad; Mehran Ghaderi; Kenji Yasuda; Pål Nyrén; Nader Pourmand
Journal:  J Biotechnol       Date:  2006-03-10       Impact factor: 3.307

6.  Analysis of read length limiting factors in Pyrosequencing chemistry.

Authors:  Foad Mashayekhi; Mostafa Ronaghi
Journal:  Anal Biochem       Date:  2007-02-13       Impact factor: 3.365

7.  Detection of gyrA mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by rapid and reliable pre-programmed short DNA sequencing.

Authors:  Baback Gharizadeh; Michael Akhras; Magnus Unemo; Bengt Wretlind; Pål Nyrén; Nader Pourmand
Journal:  Int J Antimicrob Agents       Date:  2005-11-07       Impact factor: 5.283

8.  DNA microarray format for detection and subtyping of human papillomavirus.

Authors:  Corné H W Klaassen; Clemens F M Prinsen; Hanneke A de Valk; Alphons M Horrevorts; Marcel A F Jeunink; Frederik B J M Thunnissen
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

9.  Sentinel-base DNA genotyping using multiple sequencing primers for high-risk human papillomaviruses.

Authors:  Baback Gharizadeh; Biying Zheng; Michael Akhras; Mehran Ghaderi; Olufisayo Jejelowo; Björn Strander; Pål Nyrén; Keng-Ling Wallin; Nader Pourmand
Journal:  Mol Cell Probes       Date:  2006-03-03       Impact factor: 2.365

10.  Human papillomavirus genotyping by multiplex pyrosequencing in cervical cancer patients from India.

Authors:  Cheryl M Travasso; Mona Anand; Mansi Samarth; Aditi Deshpande; Chandan Kumar-Sinha
Journal:  J Biosci       Date:  2008-03       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.